IPO Documents

Prospectus of the Company
Confirmation Depository
Listing & Trading Approval form NSE
Statement of Deviation 30.09.2023

Strategic focus on expanding its product offerings in high-growth areas such as biologics and personalized medicine, ensuring long-term sustainability and market relevance.

Our Main Services

Pharmaceutical Products
Operational Wings
R&D and Regulatory Affairs
Manufacturing &Trading wing
Formulations Manufacturing

Useful Links

About Us
Market Value
Future Growth
Our Services

Privacy Policy
Testimonials
Terms & Conditions

Total views : 1886

WhatsApp us